Evidence collected to date suggests an association between the location and the type of mutation in TOR1AIP1 with clinical presentation, which ranges from isolated cardiomyopathy to fatal progeroid-like multisystemic disorders. The gene discussed is TOR1AIP1; the disease is cardiomyopathy.